A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus. van Vollenhoven RF, Wang L, Merrill JT, Liu Y, et al. N Engl J Med 2025;393:1475-1485.

Read + Share

Amedeo Smart

Independent Medical Education

van Vollenhoven RF, Wang L, Merrill JT, Liu Y, et al. A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus. N Engl J Med 2025;393:1475-1485.
PMID: 41092329